In this respect, LRRK2 rodents greatly differ from classical toxin-induced rodent models, where overt nigro-striatal degeneration and hypokinesia are induced by acute administration of 6-OHDA or acute/subacute/chronic administration of MPTP [146–148]. The gene discussed is LRRK2; the disease is Hypokinesia.